drugset / Trial / NCT03002064
Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a phase III clinical trial to compare the efficacy of docetaxel plus cisplatin versus 5-Fu plus cisplatin in the first line chemotherapy for advanced or metastatic esophageal squamous carcinoma patients.
Timeline
- Start
- 2016-12
- Primary completion
- 2019-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 60 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 60 mg/m2 | — |
| Comparator | fluorouracil | Small molecule | 3750 mg/m2 | — |